Antimetabolites: all 7,305 studies that test it
Page 35 of 74. Open to participants first (1,098), then studies with results posted, then the rest; newest registration first within each.
- TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction AdenocarcinomaActive, not recruitingNCT04891900Not applicable
- A Study to Assess Safety and Tolerability of CC-486 (ONUREG®, Oral Azacitidine) in Combination Therapy in Participants With Acute Myeloid Leukemia (AML)CompletedNCT04887857Phase 1
- GFRα4 CAR T Cells in MTC PatientsActive, not recruitingNCT04877613Phase 1
- Gemcitabine With Ascorbate Including AdolescentsWithdrawnNCT04877587Early Phase 1
- A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow TransplantActive, not recruitingNCT04872595Phase 2
- Study of Cabozantinib Plus TAS102 in mCRC as Salvage TherapyCompletedNCT04868773Phase 1
- Venetoclax and Azacitidine for the Management of Molecular Relapse/Progression in Adult NPM1-mutated Acute Myeloid LeukemiaStatus unknownNCT04867928Phase 2
- A Phase II Study of Fruquintinib Combined With Capecitabine as First-line Treatment for Advanced Metastatic Colorectal Cancer Unsuitable for Intravenous ChemotherapyStatus unknownNCT04866108Phase 2
- Jaktinib and Azacitidine In Treating Patients With MDS With MF or MDS/MPN With MF.TerminatedNCT04866056Phase 1/2
- No Operation After Short Course Radiotherapy Followed By Consolidation Chemotherapy In Locally Advanced Rectal CancerCompletedNCT04864067Phase 2
- A Study of the Safety and PK of PCS6422 (Eniluracil) with Capecitabine in Patients with Advanced, Refractory GI Tract TumorsCompletedNCT04861987Phase 1
- Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell Transplantation in Patients With AML (Acute Myeloid Leukemia) and Myelodysplastic SyndromesActive, not recruitingNCT04861207Phase 2
- A Study of Sargramostim Plus Pembrolizumab with or Without Pemetrexed in Patients with Advance Non-small Cell Lung Cancer After Completion of ChemoimmunotherapyTerminatedNCT04856176Phase 2
- Efficacy and Safety of Low-dose Decitabine in Refractory Aplastic AnemiaTerminatedNCT04854889Phase 2
- Pediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaWithdrawnNCT04845035Phase 2
- Ruxolitinib With Calcineurin Inhibitor and Methotrexate vs. Calcineurin Inhibitor Plus Methotrexate and Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis for HLA-haploidentical Hematopoietic Stem Cell TransplantationCompletedNCT04838704Not applicable
- Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung CancerActive, not recruitingNCT04837716Phase 1
- Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy.Status unknownNCT04835064Phase 3
- A Study of Azenosertib (ZN-c3) in Combination With Gemcitabine in Subjects With OsteosarcomaCompletedNCT04833582Phase 1
- Methotrexate For The Prevention and Treatment of Proliferative Vitreoretinopathy in Pediatric PatientsWithdrawnNCT04830878Phase 1
- BST-236 as a Single Agent in Adults With Relapsed or Refractory AML or HR-MDSCompletedNCT04827719Phase 2
- Intralesional Triamcinolone Acetonide and Its Combination With 5-fluorouracil in Keloids and Hypertrophic ScarsCompletedNCT04812626Not applicable
- Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum TWEAK Level in PsoriasisStatus unknownNCT04811911Phase 4
- iTTo for Treatment Naive Advanced Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaCompletedNCT04808791Phase 2
- Neoadjuvant Nab-Paclitaxel and S-1 in Resectable Pancreatic CancerStatus unknownNCT04808687Phase 2
- Pilot Study of CC 486 (Oral Azacitidine) Plus BSC as Maintenance After sc Azacitidine in Elderly HR-IPSS-R MDS PatientsCompletedNCT04806906Phase 2
- Venetoclax + Azacitidine vs. Induction Chemotherapy in AMLActive, not recruitingNCT04801797Phase 2
- Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell LymphomaActive, not recruitingNCT04799275Phase 2/3
- Albumin-bound Paclitaxel Combination With Capecitabine Versus Capecitabine Monotherapy in Paclitaxel/Docetaxel-resistant Advanced Breast CancerStatus unknownNCT04780347Phase 2
- Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe HemoglobinopathiesWithdrawnNCT04776850Early Phase 1
- Possible Effects of Propylthiouracil, Riociguat and Perphenazine on Circulation of Healthy VolunteersCompletedNCT04776499Phase 1
- Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXRTerminatedNCT04773392Phase 4
- Osimertinib Plus Chemotherapy vs Osimertinib in EGFRm NSCLC With Persistence Week-3 ctDNA EGFRm After 1L OsimertinibCompletedNCT04769388Phase 2
- A Single Arm Study of Brain Metastasis in Patients With HER2-positive Breast CancerStatus unknownNCT04767828Phase 4
- Trial in AML Secondary to MPNs Patients, Unfit for Intensive Chemotherapy, Investigating a Treatment Combination Including Decitabine and VenetoclaxActive, not recruitingNCT04763928Phase 2
- Pain, Learning, and NoceboCompletedNCT04762836Not applicable
- Raltitrexed in HIPECCompletedNCT04761185Phase 1
- A Study of Evorpacept (ALX148) With Venetoclax and Azacitidine for Acute Myeloid Leukemia (ASPEN-05)TerminatedNCT04755244Phase 1
- Study of Pembrolizumab With Single Agent Chemotherapy in Elderly Patients With Advanced NSCLCWithdrawnNCT04754815Phase 2
- Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.Active, not recruitingNCT04753879Phase 2
- Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal AdenocarcinomaCompletedNCT04752696Phase 2
- A Phase lb/ll, Open Label, Single Arm Study With Olinvacimab and Capecitabine in mCRC Patients (OLCAP)WithdrawnNCT04751955Phase 1/2
- Hydroxyurea Therapy for Neurological and Cognitive Protection in Pediatric Sickle Cell Anemia in Uganda ( BRAINSAFE-II )CompletedNCT04750707Phase 3
- A Study of HX008 for the Treatment of Patients With Metastatic Triple Negative Breast CancerStatus unknownNCT04750382Phase 1/2
- Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDSStatus unknownNCT04749355Phase 2
- A Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combination With Venetoclax and Azacitidine in R/R Acute Myeloid Leukemia and Treatment-naïve Participants Not Eligible for Intensive TherapyTerminatedNCT04748848Phase 1
- Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid LeukemiaCompletedNCT04742101Phase 1/2
- Comparison of the Efficacy of Leflunomide and Azathioprine for the Maintenance Therapy of ANCA Associated VasculitisStatus unknownNCT04737343Not applicable
- A Phase 1 Study of ADI-001 in B Cell MalignanciesTerminatedNCT04735471Phase 1
- Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic LeukemiaActive, not recruitingNCT04734990Phase 1/2
- Fruquintinib Plus Capecitabine Versus Bevacizumab Plus Capecitabine as Maintenance Therapy Following First-line Treatment for Metastatic Colorectal CancerStatus unknownNCT04733963Phase 2
- CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine LeiomyosarcomaCompletedNCT04727242Phase 2
- Camrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer.CompletedNCT04720131Phase 2
- Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUSCompletedNCT04717908Not applicable
- Post-Surgical Injection With Triamcinolone Versus Triamcinolone/Fluorouracil in Treatment of KeloidsCompletedNCT04710719Not applicable
- Novel BCMA-targeted CAR-T Cell Therapy for Multiple MyelomaStatus unknownNCT04706936Phase 1
- Decitabine-primed Tandem CD19/CD20 CAR T Cells Treatment in r/r B-NHLActive, not recruitingNCT04697940Phase 1/2
- Non-OpeRative MANagement of Rectal Cancer PatientsCompletedNCT04696757Phase 2
- Osimertinib Monotherapy or Combination With Chemotherapy for Advanced NSCLC Concurrent EGFR and TP53 MutationsActive, not recruitingNCT04695925Phase 3
- ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple SclerosisActive, not recruitingNCT04695080Phase 2/3
- Efficacy and Safety of S-1 Plus Oxaliplatin in First-line Treatment of Ederly Patients With Advanced Gastric CancerStatus unknownNCT04694404Phase 2
- Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years OldCompletedNCT04687761Phase 1/2
- Risk-adapted Therapy for Primary Acute Myeloid LeukemiaCompletedNCT04687098Phase 2
- Pemetrexed and TAS-102 in Combination With Bevacizumab in Refractory Colorectal CancerStatus unknownNCT04683965Phase 2
- MTX and Steroid for aGVHD TreatmentStatus unknownNCT04677868Phase 2
- A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or CholangiocarcinomaStatus unknownNCT04668976Phase 2
- CPX-351 as a Novel Approach for the Treatment of Older Patients With AML and MDSActive, not recruitingNCT04668885Phase 2
- A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the BladderActive, not recruitingNCT04658862Phase 3
- Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.Active, not recruitingNCT04654988Phase 4
- Aerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial MalignanciesWithdrawnNCT04648826Phase 1/2
- A Study of AK104 in Patients With Locally Advanced or Metastatic Non-small Cell Lung CancerCompletedNCT04647344Phase 1/2
- Doxorubicin, CC-(486) (5-azacitidine), Romidepsin, and Duvelisib (hARD) for T-cell LymphomaWithdrawnNCT04639843Phase 1
- CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)Active, not recruitingNCT04637763Phase 1
- Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic CancerCompletedNCT04634539Phase 1
- Intravesical Recombinant BCG Followed by Perioperative Chemo-immunotherapy for Patients With MIBCActive, not recruitingNCT04630730Phase 2
- A Trial of LONSURF in Recurrent/Metastatic Nasopharyngeal CarcinomaStatus unknownNCT04627961Phase 2
- CAR-T for Children With Relapsed and Refractory Acute Lymphoblastic LeukemiaStatus unknownNCT04626765Early Phase 1
- CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple MyelomaStatus unknownNCT04626752Early Phase 1
- CAR-T Cells in Treating Patients With Relapsed or Refractory NHLStatus unknownNCT04626739Early Phase 1
- Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell TransplantationStatus unknownNCT04626726Early Phase 1
- A Study to Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC.TerminatedNCT04619433Phase 3
- AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic CancerStatus unknownNCT04617821Phase 3
- Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS LymphomaActive, not recruitingNCT04609046Phase 1
- A Clinical Study of PD-L1 Antibody ZKAB001 Combined With Capecitabine in Resected Biliary Tract CancerStatus unknownNCT04608786Phase 1
- Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic AdenocarcinomaActive, not recruitingNCT04594772Phase 2
- Almonertinib/Pemetrexed/Carboplatin in EGFR T790M+ Advanced Lung CancerStatus unknownNCT04592666Phase 2
- Adalimumab Plus Methotrexate for the Treatment of Pediatric UveitisStatus unknownNCT04588818Phase 2
- Dynamic PET/CT Evaluated the Response of Neoadjuvant Anti-PD1 Combination With Chemotherapy for Ⅱa-Ⅲb NSCLCStatus unknownNCT04586465Phase 2
- Fruquintinib and Raltitrexed Versus Fruquintinib Monotherapy in Advanced Colorectal CancerStatus unknownNCT04582981Phase 2
- The Safety and Efficacy of the Combination of Raltitrexed for Injection and Nab-Paclitaxel in Advanced Pancreatic CancerStatus unknownNCT04581876Phase 2
- Methotrexate in Erosive Inflammatory Hand OsteoarthritisActive, not recruitingNCT04579848Phase 4
- ²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple MyelomaWithdrawnNCT04579523Phase 1
- Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial CancerActive, not recruitingNCT04579224Phase 3
- CC-486, Lenalidomide, and Obinutuzumab for the Treatment of Recurrent or Refractory CD20 Positive B-cell LymphomaCompletedNCT04578600Phase 1
- Letrozole and Metronomic Capecitabine in ER-positive HER2 Negative Advanced Breast Cancer (B-001 Study)Status unknownNCT04571437Phase 2
- Primary Excision Combined With Preoperative Neoadjuvant and Adjuvant Therapy for Oligometastasis of Urothelial CarcinomaCompletedNCT04570410Phase 2
- Trifluridine/Tipiracil in Combination With Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients.Active, not recruitingNCT04564898Phase 1/2
- Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic NeoplasiaActive, not recruitingNCT04562558Not applicable
- Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder CancerActive, not recruitingNCT04559139Phase 2/3
- Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder CancerCompletedNCT04553939Phase 2